# NO AD: Use of Nitric Oxide (NO) Donors for the Prevention of Autonomic Dysreflexia (AD) During Bowel Care Following SCI

> **NCT05635851** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Simon Fraser University** · enrollment: 26 (estimated)

## Conditions studied

- Spinal Cord Injuries
- Autonomic Dysreflexia

## Interventions

- **DRUG:** Glyceryl Trinitrate Only Product in Oromucosal Dose Form
- **OTHER:** Placebo sublingual spray

## Key facts

- **NCT ID:** NCT05635851
- **Lead sponsor:** Simon Fraser University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05635851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05635851, "NO AD: Use of Nitric Oxide (NO) Donors for the Prevention of Autonomic Dysreflexia (AD) During Bowel Care Following SCI". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05635851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*